Stock A287410 JEISYS MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Jeisys Medical Inc. Share Price

Equities

A287410

KR7287410005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
9,450 KRW +0.85% Intraday chart for Jeisys Medical Inc. -21.38% -9.91%
11/04 AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan CI
04/04 AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc. CI

Financials

Sales 2024 * 183B 133M 11.08B Sales 2025 * 210B 153M 12.74B Capitalization 713B 518M 43.18B
Net income 2024 * 45B 32.72M 2.73B Net income 2025 * 51B 37.08M 3.09B EV / Sales 2024 * 3.63 x
Net cash position 2024 * 48.85B 35.51M 2.96B Net cash position 2025 * 81.53B 59.27M 4.94B EV / Sales 2025 * 3 x
P/E ratio 2024 *
16 x
P/E ratio 2025 *
14.1 x
Employees 231
Yield 2024 *
-
Yield 2025 *
-
Free-Float 69.08%
More Fundamentals * Assessed data

Chart Jeisys Medical Inc.

Dynamic Chart

Latest news about Jeisys Medical Inc.

AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan CI
AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc. CI
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023. CI
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023. CI
Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million. CI
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China MT
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023. CI
Jeisys Medical Inc. announces an Equity Buyback. CI
Jeisys Medical Inc. authorizes a Buyback Plan. CI
Jeisys Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Cynosure KK Enters into Distribution Partnership with Jeisys Medical KK in Japan CI
Jeisys Medical Inc.(KOSDAQ:A287410) added to S&P Global BMI Index CI
SACCI Bio Co., Ltd. announced that it expects to receive KRW 2.85 billion in funding from Jeisys Medical Inc. CI
Jeisys Medical Inc. completed the acquisition of Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others in a reverse merger transaction. CI
Jeisys Medical Inc. signed a contract to acquire Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others for approximately KRW 300 billion in a reverse merger transaction. CI
More news

Quotes and Performance

1 day+0.85%
1 week-21.38%
Current month+18.72%
1 month+18.57%
3 months+8.37%
6 months-10.00%
Current year-9.91%
More quotes

Highs and lows

1 week
9 090.00
Extreme 9090
11 700.00
1 month
7 950.00
Extreme 7950
12 650.00
Current year
7 390.00
Extreme 7390
12 650.00
1 year
7 390.00
Extreme 7390
14 500.00
3 years
4 380.00
Extreme 4380
14 500.00
5 years
3 540.00
Extreme 3540
14 500.00
10 years
3 540.00
Extreme 3540
14 500.00
More quotes

Managers and Directors - Jeisys Medical Inc.

Managers TitleAgeSince
Jong-Hwan Kim CEO
 Chief Executive Officer 56 -
Bo-Gun Jeong AUD
 Comptroller/Controller/Auditor 47 -
Members of the board TitleAgeSince
Jong-Hwan Kim CEO
 Chief Executive Officer 56 -
Hong-Sik Park BRD
 Director/Board Member 46 -
Ji-Su Park BRD
 Director/Board Member 52 -
More insiders

ETFs positioned on Jeisys Medical Inc.

Name Weight AuM 1st Jan change Investor Rating
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.00% 4 M€ -4.41% -
More ETFs positioned on Jeisys Medical Inc.

Quotes

Date Price Change Volume
26/24/26 9,450 +0.85% 3,485,823
25/24/25 9,370 -12.35% 4,563,433
24/24/24 10,690 +5.63% 2,323,380
23/24/23 10,120 -4.80% 2,776,024
22/24/22 10,630 -11.56% 6,374,695

End-of-day quote Korea S.E., April 26, 2024

More quotes

Company Profile

Jeisys Medical Inc, formerly Yuanta 3 Special Purpose Acquisition Co Ltd, a Korea-based company principally engaged in the manufacturing and distribution of medical devices. The Company manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
Sector
Advanced Medical Equipment & Technology
Calendar
09/05/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Jeisys Medical Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
9,450 KRW
Average target price
14,038 KRW
Spread / Average Target
+48.54%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
JEISYS MEDICAL INC. Stock Jeisys Medical Inc.
-9.91% 518M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. A287410 Stock